Insight

Paolo Ciracì: Late-line options for patients with metastatic colorectal cancer

Paolo Ciracì/LinkedIn

Nov 20, 2024, 19:12

Paolo Ciracì: Late-line options for patients with metastatic colorectal cancer

A recent paper by Paolo Ciracì, Medical Oncology Resident at the University Hospital of Pisa, was mentioned by Nieves Martinez Lago, Medical Oncologist at the University Hospital Complex of Ferrol, on X:

“Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm

FTD/TPI+BEV, REG and FRU for unselected patients.
Targeted Therapies for patients With Oncogenic Driver Molecular Alterations.
Rechallenge antiEGFR in patients ctDNA RAS/BRAF wild-type.”

“Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm”

Authors: Paolo Ciracì, Vittorio Studiale, Ada Taravella, Carlotta Antoniotti, Chiara Cremolini.

For more posts like this, visit oncodaily.com.

Ada Taravella cancer Carlotta Antoniotti Chiara Cremolini clinical trials Metastatic colorectal cancer Nieves Martinez Lago OncoDaily Oncology Paolo Ciracì Vittorio Studiale

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Special Coverage